INAB
IN8bio, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
IN8bio (INAB) Stock: Buy, Sell, or Hold?
$0.87
-0.03 (-3.14%)
▼
5d:
-6.34%
30d:
-26.13%
90d:
-26.13%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (90%)
Quality Score
58/100
Position
OVERSOLD
30-Day Fair Range
$0.91 – $1.26
Position: OVERSOLD
Forward P/E & Valuation
-0.9x
Next 12M consensus est.
Wall Street Target
$7.00
+703.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.80 / $1.01
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: INAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When INAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INAB is currently trading at $0.87, which is considered oversold relative to its 30-day fair value range of $0.91 to $1.26.
Technical Outlook: Technically, INAB is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.01. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: INAB scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+703.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INAB is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.01. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: INAB scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+703.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.91 -
$1.26
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$0.91 -
$1.26
Current vs Trading Range
OVERSOLD
Support Level
$0.80
Resistance Level
$1.01
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 703.0% below Wall St target ($7.00)
- CAUTION: Bottoming setup, but lagging the sector by 17% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-6.3%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-0.92
Wall Street Target
$7.00
(+703.0%)
Share INAB Analysis
Share this live INAB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INAB)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 1, 2026
Daily AI digest
AI Retail Discussion Summary:
One bullish trader on StockTwits reported closing out profitable gains on $INAB shares.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:16 AM ET
Data refreshes hourly during market hours. Next update: 8:16 AM
Data refreshes hourly during market hours. Next update: 8:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 44 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 55 HOLD |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 35 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INAB Research Pages
